Atrial fibrillation, familial, 8

Synonyms: ATFB8

Summary

Atrial fibrillation is the most common sustained cardiac rhythm disturbance, affecting more than 2 million Americans, with an overall prevalence of 0.89%. The prevalence increases rapidly with age, to 2.3% between the ages of 40 and 60 years, and to 5.9% over the age of 65. The most dreaded complication is thromboembolic stroke (Brugada et al., 1997). For a discussion of genetic heterogeneity of atrial fibrillation, see 608583. [from OMIM]

Available tests

1 test is in the database for this condition.

Clinical tests (1 available)

Molecular Genetics Tests

Genes See tests for all associated and related genes

Associated genes Help
Genes reported to contribute to the condition.

ZFHX3
19 tests
Also known as: ATBF1, ATBT, ATFB8, C16orf47, SCA4, ZFH-3, ZNF927, ZFHX3
Summary: zinc finger homeobox 3

Imported from Human Phenotype Ontology (HPO)

Show all Hide all

Abnormality of the cardiovascular system
- Atrial fibrillation
  Atrial fibrillation
  - MedGen UID: 445
  - Concept ID: C0004238
  - Finding: Finding
  Abnormality of the cardiovascular system
  See: Feature record | Search on this feature

Reviews

Clinical resources

Practice guidelines

NICE, 2021
UK NICE Guideline NG196, Atrial fibrillation: diagnosis and management, 2021

Molecular resources

Consumer resources

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.